Back

Incidence and exploratory analysis of cancer development after new on-set atrial fibrillation

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePosters Day 2 Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Javier Quesada-Ocete

GENERAL UNIVERSITY HOSPITAL OF VALENCIA CONSORTIUM, Valencia (Spain)

131 More presentations in this session

Presentation thumbnail
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides
Presentation thumbnail
Pure and impure tachycardiomiopathy: key differences and long term prognosis
Doctor G. Stronati (Ancona, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation
Professor D. Lashkul (Zaporizhzhya, UA)
Abstract Slides
Presentation thumbnail
Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults
Mr E. Abdovic (Zenica, BA)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score and the risk of death in atrial fibrillation
Doctor A. Aro (Helsinki, FI)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 2

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources